THE EUROPEAN Parliament has widened health research under the oncoming EU Sixth Framework Programme to include studies on traditional diseases, widening European Commission plans to limiting its life science work to genomics and biotechnology. By contrast, the parliament wants money spent on cancer, cardiovascular diseases, degenerative nervous system illnesses, (including CJD), diabetes, viral hepatitis C, allergies, rare diseases and ageing conditions.

These changes have been incorporated in the programme as formal amendments. They ...

Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.